Assessing the clinical utility of biomarkers using the intervention probability curve (IPC)

CONCLUSIONS: The IPC methodology can be a valuable tool for assessing biomarkers prior to clinical implementation.PMID:38073376 | DOI:10.3233/CBM-230054

Source: Cancer Biomarkers - December 11, 2023 Category: Cancer & Oncology Authors: Rafael Paez Dianna J Rowe Stephen A Deppen Eric L Grogan Alexander Kaizer Darryl J Bornhop Amanda K Kussrow Anna E Bar ón Fabien Maldonado Michael N Kammer Source Type: research